Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 35.15
-1.60 (-4.35%)
May 29, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 14.26 billion as of May 29, 2026. Its market cap has increased by 119.70% in one year.
Market Cap
14.26B
Enterprise Value
14.50B
Revenue
774.47M
Ranking
n/a
PE Ratio
251.94
Stock Price
35.15
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 14.26B, a decrease of -11.81%. That is a compound annual growth rate of -2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 14.26B | 38.53% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.99B |
| Anhui Anke Biotechnology (Group) | 13.87B |
| Mabwell (Shanghai) Bioscience | 13.04B |
| Jinyu Bio-technology | 12.75B |
| Staidson (Beijing) BioPharmaceuticals | 12.32B |
| Pacific Shuanglin Bio-pharmacy | 12.26B |
| Tibet Cheezheng Tibetan Medicine | 11.93B |
| HitGen | 11.84B |